Next Article in Journal
Pivotal Shigella Vaccine Efficacy Trials—Study Design Considerations from a Shigella Vaccine Trial Design Working Group
Next Article in Special Issue
Dual-Positive MPO- and PR3-ANCA-Associated Vasculitis Following SARS-CoV-2 mRNA Booster Vaccination: A Case Report and Systematic Review
Previous Article in Journal
Comparison of CLEIA and ELISA for SARS-CoV-2 Virus Antibodies after First and Second Dose Vaccinations with the BNT162b2 mRNA Vaccine
Previous Article in Special Issue
New-Onset Kidney Diseases after COVID-19 Vaccination: A Case Series
 
 
Review

Article Versions Notes

Vaccines 2022, 10(4), 488; https://doi.org/10.3390/vaccines10040488
Action Date Notes Link
article xml file uploaded 22 March 2022 12:14 CET Original file -
article xml uploaded. 22 March 2022 12:14 CET Update https://www.mdpi.com/2076-393X/10/4/488/xml
article pdf uploaded. 22 March 2022 12:14 CET Version of Record https://www.mdpi.com/2076-393X/10/4/488/pdf
article html file updated 22 March 2022 12:15 CET Original file https://www.mdpi.com/2076-393X/10/4/488/html
Back to TopTop